mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference73 articles.
1. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E;Fingar;Mol Cell Biol,2004
2. Defining the role of mTOR in cancer;Guertin;Cancer Cell,2007
3. Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin;Hudson;Mol Cell Biol,2002
4. Activation of the HIF pathway in cancer;Maxwell;Curr Opin Genet Dev,2001
5. TOR signaling in growth and metabolism;Wullschleger;Cell,2006
Cited by 95 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Assessing the antitumor effects of metformin on ovarian clear cell carcinoma;Human Cell;2024-08-08
2. New Investigational Drug’s Targeting Various Molecular Pathways for Treatment of Cervical Cancer: Current Status and Future Prospects;Cancer Investigation;2024-07-05
3. The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review;Cancers;2024-06-06
4. Comparative effects of progestin-based combination therapy for endometrial cancer or atypical endometrial hyperplasia: a systematic review and network meta-analysis;Frontiers in Oncology;2024-05-03
5. Optimized Detection of Ovarian Cancer Using Segmentation with FR-CNN Classification;Lecture Notes in Electrical Engineering;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3